Does PEMBROLIZUMAB Cause Ecchymosis? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Ecchymosis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
11
Reports of Ecchymosis with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
3
Deaths
9
Hospitalizations
How Dangerous Is Ecchymosis From PEMBROLIZUMAB?
Of the 11 reports, 3 (27.3%) resulted in death, 9 (81.8%) required hospitalization, and 2 (18.2%) were considered life-threatening.
Is Ecchymosis Listed in the Official Label?
Yes, Ecchymosis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Ecchymosis?
RIVAROXABAN (398)
ASPIRIN (344)
WARFARIN (248)
CLOPIDOGREL BISULFATE (205)
IBRUTINIB (189)
APIXABAN (154)
METHOTREXATE (131)
PREDNISONE (118)
TOCILIZUMAB (92)
DABIGATRAN ETEXILATE (79)
Which PEMBROLIZUMAB Alternatives Have Lower Ecchymosis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G